A 27-year-old G0P0 female presents to her OB/GYN for a preconception visit to seek advice before becoming pregnant. A detailed history reveals no prior medical or surgical history, and she appears to be in good health currently. Her vaccination history is up-to-date. She denies tobacco or recreational drug use and admits to drinking 2 glasses of wine per week. She states that she is looking to start trying to become pregnant within the next month, hopefully by the end of January. Which of the following is NOT recommended as a next step for this patient's preconception care?
Q112
A 35-year-old woman, gravida 4, para 3, at 34 weeks' gestation comes to the physician for a prenatal visit. She feels well. She does not note any contractions or fluid from her vagina. Her third child was delivered spontaneously at 35 weeks' gestation; pregnancy and delivery of her other two children were uncomplicated. Vital signs are normal. The abdomen is nontender and no contractions are felt. Pelvic examination shows a uterus consistent in size with a 34-weeks' gestation. Ultrasonography shows the fetus in a breech presentation. The fetal heart rate is 148/min. Which of the following is the most appropriate next step in management?
Q113
A 26-year-old nurse at 8 weeks of gestation presents to the physician with low-grade fever and body ache for the past 2 days. She also complains of a fine pink and itchy rash that appeared 2 nights ago. The rash 1st appeared on her face and spread to her neck. Past medical history is noncontributory. She takes prenatal vitamins with folate every day. She has had many sick contacts while working in the hospital. Additionally, her daughter has had several colds over the last few months. On examination, the temperature is 38.3°C (100.9°F), she has a fine macular rash on her face and neck with focal macules on her chest. Palpation of the neck reveals lymphadenopathy in the posterior auricular nodes. What is the most appropriate next step in the management of this patient?
Q114
A 27-year-old G1P0 at 12 weeks estimated gestational age presents for prenatal care. The patient says she has occasional nausea and vomiting and a few episodes of palpitations and diarrhea this last week. Physical examination is unremarkable, except for a heart rate of 145/min. Basic thyroid function tests are shown in the table below. Which of the following additional laboratory tests would be most useful in assessing this patient's condition?
Thyroid-stimulating hormone (TSH)
0.28 mIU/L (0.3–4.5 mIU/L)
Total T4
12 µg/dL (5.4–11.5 µg/dL)
Q115
A 16-year-old girl comes to the physician because of episodic lower abdominal pain for 5 months. The pain starts to occur a few hours before her menses and lasts for 2–3 days. Ibuprofen helped reduce the pain in the first months but has no effect now. She has missed a couple of days at school because of severe pain. Menarche was at the age of 14 years, and menses occur at regular 29-day intervals. She is sexually active with one male partner and uses condoms inconsistently. Her temperature is 37.1°C (98.8°F), pulse is 88/min, and blood pressure is 110/70 mm Hg. Physical and pelvic examination show no abnormalities. A urine pregnancy test is negative. Which of the following is the most appropriate next step in management?
Q116
A 3670-g (8 lb 1 oz) male newborn is delivered to a 26-year-old primigravid woman. She received adequate prenatal care and labor was uncomplicated. She has chronic hepatitis B infection and gastroesophageal reflux disease. Her only medication is ranitidine. She admits to smoking cannabis and one half-pack of cigarettes daily. She drinks two beers on the weekend. The mother is apprehensive about taking care of her baby and requests for some information regarding breastfeeding. Which of the following is a contraindication to breastfeeding?
Q117
A 21-year-old gravida 1 presents to her physician's office for an antepartum visit at 11 weeks gestation. She has complaints of malaise, occasional nausea, and changes in food preferences. Her vital signs include: blood pressure 100/70 mm Hg, heart rate 90/min, respiratory rate 14/min, and temperature 36.8℃ (98.2℉). Examination reveals a systolic ejection murmur along the left sternal border. There are no changes in skin color, nails, or hair growth. No neck enlargement is noted. Blood analysis shows the following:
Erythrocyte count 3.5 million/mm3
Hb 11.9 g/dL
HCT 35%
Reticulocyte count 0.2%
MCV 85 fL
Platelet count 210,000/mm3
Leukocyte count 7800/mm3
Serum iron 17 µmol/L
Ferritin 120 µg/L
What is the most likely cause of the changes in the patient's blood count?
Q118
A 24-year-old woman comes to the physician for preconceptional advice. She has been married for 2 years and would like to conceive within the next year. Menses occur at regular 30-day intervals and last 4 days with normal flow. She does not smoke or drink alcohol and follows a balanced diet. She takes no medications. She is 160 cm (5 ft 3 in) tall and weighs 55 kg (121 lb); BMI is 21.5 kg/m2. Physical examination, including pelvic examination, shows no abnormalities. She has adequate knowledge of the fertile days of her menstrual cycle. Which of the following is most appropriate recommendation for this patient at this time?
Q119
A 21-year-old female presents to her primary care doctor for prenatal counseling before attempting to become pregnant for the first time. She is an avid runner, and the physician notes her BMI of 17.5. The patient complains of chronic fatigue, which she attributes to her busy lifestyle. The physician orders a complete blood count that reveals a Hgb 10.2 g/dL (normal 12.1 to 15.1 g/dL) with an MCV 102 µm^3 (normal 78 to 98 µm^3). A serum measurement of a catabolic derivative of methionine returns elevated. Which of the following complications is the patient at most risk for if she becomes pregnant?
Q120
A 23-year-old woman presents to her physician requesting the chickenpox vaccine. She is also complaining of nausea, malaise, and moderate weight gain. She developed these symptoms gradually over the past 2 weeks. She reports no respiratory or cardiovascular disorders. Her last menstruation was about 6 weeks ago. She has one sexual partner and uses a natural planning method for contraception. Her vital signs include: blood pressure 110/70 mm Hg, heart rate 92/min, respiratory rate 14/min, and temperature 37.2℃ (99℉). The physical examination shows non-painful breast engorgement and nipple hyperpigmentation. There is no neck enlargement and no palpable nodules in the thyroid gland. The urine beta-hCG is positive. What is the proper recommendation regarding chickenpox vaccination in this patient?
Prenatal Care US Medical PG Practice Questions and MCQs
Question 111: A 27-year-old G0P0 female presents to her OB/GYN for a preconception visit to seek advice before becoming pregnant. A detailed history reveals no prior medical or surgical history, and she appears to be in good health currently. Her vaccination history is up-to-date. She denies tobacco or recreational drug use and admits to drinking 2 glasses of wine per week. She states that she is looking to start trying to become pregnant within the next month, hopefully by the end of January. Which of the following is NOT recommended as a next step for this patient's preconception care?
A. Begin 400 mcg folic acid supplementation
B. Administer measles, mumps, rubella (MMR) vaccination (Correct Answer)
C. Obtain rubella titer
D. Obtain varicella zoster titer
E. Recommend inactivated influenza vaccination
Explanation: ***Administer measles, mumps, rubella (MMR) vaccination***
- Live-attenuated vaccines like **MMR** are contraindicated during pregnancy and should ideally be given **at least one month prior to conception**.
- If her vaccination history is up-to-date and she plans to conceive within the month, administering MMR is not recommended at this time without confirming immunity first.
*Begin 400 mcg folic acid supplementation*
- **Folic acid supplementation** at 400 mcg daily is recommended for all women of childbearing age to prevent **neural tube defects**, ideally starting at least one month before conception and continuing through the first trimester.
- This is a crucial step in preconception care to ensure adequate levels when the neural tube is forming.
*Obtain rubella titer*
- Checking a **rubella titer** is standard preconception care to determine immunity, as rubella infection during pregnancy can lead to serious congenital anomalies.
- If she is not immune, the MMR vaccine can be offered, but with a **one-month contraception period** before attempting conception.
*Obtain varicella zoster titer*
- Determining **varicella immunity** is important because congenital varicella syndrome can occur if a non-immune mother contracts chickenpox during pregnancy.
- If she is not immune, the **varicella vaccine** can be administered, followed by a **one-month waiting period** before conception.
*Recommend inactivated influenza vaccination*
- **Inactivated influenza vaccination** is safe and recommended during any stage of pregnancy, including the preconception period, to protect both the mother and newborn from severe influenza outcomes.
- It can be given even if she plans to conceive within the month, as it is not a live vaccine.
Question 112: A 35-year-old woman, gravida 4, para 3, at 34 weeks' gestation comes to the physician for a prenatal visit. She feels well. She does not note any contractions or fluid from her vagina. Her third child was delivered spontaneously at 35 weeks' gestation; pregnancy and delivery of her other two children were uncomplicated. Vital signs are normal. The abdomen is nontender and no contractions are felt. Pelvic examination shows a uterus consistent in size with a 34-weeks' gestation. Ultrasonography shows the fetus in a breech presentation. The fetal heart rate is 148/min. Which of the following is the most appropriate next step in management?
A. Internal cephalic version
B. Intravenous penicillin
C. Cesarean section
D. Observation (Correct Answer)
E. External cephalic version
Explanation: ***Observation***
- At 34 weeks' gestation, **spontaneous version** from **breech to cephalic presentation** can still occur, especially in multiparous women.
- Waiting until 37 weeks allows time for the fetus to turn naturally before considering interventions.
*Internal cephalic version*
- This procedure involves a physician inserting a hand into the uterus to manually turn the fetus from inside.
- It is typically performed during **labor** to correct a **malpresentation** once the cervix is dilated sufficiently and is not appropriate for an antepartum breech presentation.
*Intravenous penicillin*
- **Penicillin** is administered to prevent **Group B Streptococcus (GBS) transmission** to the neonate, usually during labor for GBS-positive mothers.
- There is no indication for **GBS prophylaxis** in this case, and GBS status is not provided.
*Cesarean section*
- While breech presentation often necessitates a **cesarean section**, it is generally planned for 39 weeks' gestation or when labor begins if other interventions fail.
- It is premature to schedule a **C-section** at 34 weeks, as the fetus might still undergo spontaneous version.
*External cephalic version*
- This procedure involves manually manipulating the fetus through the maternal abdomen to turn it from breech to cephalic.
- It is usually attempted at **37 weeks' gestation** to maximize success rates and minimize risks, as earlier attempts have lower success and higher re-version rates.
Question 113: A 26-year-old nurse at 8 weeks of gestation presents to the physician with low-grade fever and body ache for the past 2 days. She also complains of a fine pink and itchy rash that appeared 2 nights ago. The rash 1st appeared on her face and spread to her neck. Past medical history is noncontributory. She takes prenatal vitamins with folate every day. She has had many sick contacts while working in the hospital. Additionally, her daughter has had several colds over the last few months. On examination, the temperature is 38.3°C (100.9°F), she has a fine macular rash on her face and neck with focal macules on her chest. Palpation of the neck reveals lymphadenopathy in the posterior auricular nodes. What is the most appropriate next step in the management of this patient?
A. Administer rubella vaccine
B. Termination of pregnancy
C. Admit the patient and place her in isolation
D. Administer anti-rubella antibodies
E. Test for rubella antibodies in her blood (Correct Answer)
Explanation: ***Test for rubella antibodies in her blood***
- The patient's symptoms (low-grade fever, body ache, fine maculopapular rash spreading from face to neck, posterior auricular lymphadenopathy) are highly suggestive of **rubella (German measles)**.
- Due to the risk of **congenital rubella syndrome** in pregnancy, confirming the diagnosis with **IgM and IgG rubella antibody titers** is the most appropriate initial step to assess recent infection and immunity status.
*Administer rubella vaccine*
- The rubella vaccine is a **live attenuated vaccine** and is **contraindicated in pregnancy** due to the theoretical risk of fetal infection.
- Vaccination should only be performed **postpartum** or when pregnancy is not a concern.
*Termination of pregnancy*
- **Termination of pregnancy** is a significant decision and is only considered in cases of confirmed severe congenital rubella syndrome, after extensive counseling, and in line with patient wishes.
- This step is **premature** and should not be considered until a rubella infection is confirmed and the potential fetal risks are thoroughly evaluated.
*Admit the patient and place her in isolation*
- While isolation might be necessary if rubella is confirmed due to its **infectious nature**, this is not the **first step** in management.
- The priority is to **confirm the diagnosis** to guide further appropriate medical and obstetric decisions.
*Administer anti-rubella antibodies*
- **Passive immunization with immunoglobulin** might be considered in specific cases of non-immune pregnant women exposed to rubella, but its efficacy in preventing congenital rubella syndrome is **uncertain** and it is not a first-line treatment for an active suspected infection.
- The immediate priority is accurate diagnosis through **antibody testing**.
Question 114: A 27-year-old G1P0 at 12 weeks estimated gestational age presents for prenatal care. The patient says she has occasional nausea and vomiting and a few episodes of palpitations and diarrhea this last week. Physical examination is unremarkable, except for a heart rate of 145/min. Basic thyroid function tests are shown in the table below. Which of the following additional laboratory tests would be most useful in assessing this patient's condition?
Thyroid-stimulating hormone (TSH)
0.28 mIU/L (0.3–4.5 mIU/L)
Total T4
12 µg/dL (5.4–11.5 µg/dL)
A. Thyrotropin receptor antibodies (TRAb)
B. Total triiodothyronine (T3) levels
C. Thyroid peroxidase (TPO) antibodies
D. Free thyroxine (T4) levels (Correct Answer)
E. Thyroxine-binding globulin (TBG) levels
Explanation: ***Free thyroxine (T4) levels***
- In pregnancy, **estrogen increases thyroxine-binding globulin (TBG)**, leading to higher **total T4** levels even if free T4 is normal.
- Measuring **free T4 provides a more accurate assessment** of the biologically active thyroid hormone, which is crucial for distinguishing between physiological changes of pregnancy and true hyperthyroidism.
*Thyrotropin receptor antibodies (TRAb)*
- **TRAb are specific for Graves' disease**, which is a cause of hyperthyroidism, but their presence is a confirmatory test after hyperthyroidism has been established.
- The initial step is to confirm the diagnosis of **hyperthyroidism** by evaluating free hormone levels, particularly in pregnancy where total hormone levels are less reliable.
*Total triiodothyronine (T3) levels*
- Similar to total T4, **total T3 levels are also affected by increased TBG in pregnancy**, making them less reliable for initial diagnosis of thyroid dysfunction.
- While T3 is an important thyroid hormone, **free T4 is generally the primary screening test** for hyperthyroidism.
*Thyroid peroxidase (TPO) antibodies*
- **TPO antibodies are indicative of autoimmune thyroiditis**, such as Hashimoto's thyroiditis, which typically causes hypothyroidism, not hyperthyroidism, as suggested by the patient's symptoms and elevated T4.
- Although TPO antibodies can sometimes be positive in Graves' disease, they are **not the primary diagnostic test for active hyperthyroidism**, especially regarding the magnitude of the elevation.
*Thyroxine-binding globulin (TBG) levels*
- While **TBG levels are elevated in pregnancy**, measuring TBG itself doesn't directly assess thyroid function.
- Understanding the physiology of **TBG elevation explains why total T4 is high**, but it doesn't help in determining whether the patient is truly hyperthyroid; for that, free T4 is needed.
Question 115: A 16-year-old girl comes to the physician because of episodic lower abdominal pain for 5 months. The pain starts to occur a few hours before her menses and lasts for 2–3 days. Ibuprofen helped reduce the pain in the first months but has no effect now. She has missed a couple of days at school because of severe pain. Menarche was at the age of 14 years, and menses occur at regular 29-day intervals. She is sexually active with one male partner and uses condoms inconsistently. Her temperature is 37.1°C (98.8°F), pulse is 88/min, and blood pressure is 110/70 mm Hg. Physical and pelvic examination show no abnormalities. A urine pregnancy test is negative. Which of the following is the most appropriate next step in management?
A. Diagnostic laparoscopy
B. Oral contraceptive pill (Correct Answer)
C. Ceftriaxone and doxycycline therapy
D. Urinalysis
E. Pelvic ultrasonography
Explanation: ***Oral contraceptive pill***
- This patient's symptoms are highly suggestive of **secondary dysmenorrhea**, possibly due to **endometriosis**, given the worsening pain and lack of response to NSAIDs. **Oral contraceptive pills (OCPs)** are a first-line treatment for dysmenorrhea, including that caused by endometriosis, as they suppress ovulation and reduce endometrial growth.
- The patient also reports inconsistent condom use and is sexually active, making OCPs a beneficial choice for **contraception**, addressing two concerns simultaneously.
*Diagnostic laparoscopy*
- **Laparoscopy** is the gold standard for diagnosing endometriosis, but it is an **invasive surgical procedure**.
- It is generally reserved for cases where empirical medical therapy has failed or when there is a strong suspicion of severe disease or infertility.
*Ceftriaxone and doxycycline therapy*
- This antibiotic regimen is used to treat **pelvic inflammatory disease (PID)**. While the patient is sexually active and uses condoms inconsistently, she presents with no signs of active infection (e.g., fever, cervical motion tenderness, purulent discharge), making empiric antibiotics unwarranted at this stage.
- Her pain is also clearly cyclical and related to menses, which is more characteristic of dysmenorrhea.
*Urinalysis*
- A **urinalysis** would be appropriate if there were symptoms suggestive of a **urinary tract infection (UTI)**, such as dysuria, frequency, urgency, or hematuria.
- The patient's symptoms are primarily cyclical lower abdominal pain, which is not typical for a UTI.
*Pelvic ultrasonography*
- **Pelvic ultrasonography** is a non-invasive imaging technique that can help identify structural abnormalities like **ovarian cysts**, **fibroids**, or adenomyosis.
- However, it often cannot reliably detect mild endometriosis and a normal ultrasound does not rule out the condition. Given the classic symptoms of dysmenorrhea, empirical treatment often precedes imaging.
Question 116: A 3670-g (8 lb 1 oz) male newborn is delivered to a 26-year-old primigravid woman. She received adequate prenatal care and labor was uncomplicated. She has chronic hepatitis B infection and gastroesophageal reflux disease. Her only medication is ranitidine. She admits to smoking cannabis and one half-pack of cigarettes daily. She drinks two beers on the weekend. The mother is apprehensive about taking care of her baby and requests for some information regarding breastfeeding. Which of the following is a contraindication to breastfeeding?
A. Cannabis use (Correct Answer)
B. Ranitidine use
C. Hepatitis B infection
D. Smoking
E. Seropositive for cytomegalovirus
Explanation: ***Cannabis use***
- **Cannabis** and its active compounds, particularly **tetrahydrocannabinol (THC)**, are secreted into breast milk and can accumulate in breastfed infants' adipose tissue and brain.
- Exposure via breast milk can lead to potential neurodevelopmental effects, sedation, and impaired motor development in the infant, making it a contraindication to breastfeeding.
*Ranitidine use*
- **Ranitidine** (now largely replaced by famotidine) is generally considered safe during breastfeeding because only very small amounts are transferred into breast milk and are unlikely to cause adverse effects in the infant.
- The benefits of breastfeeding typically outweigh the minimal risks associated with commonly used medications like ranitidine for maternal conditions.
*Hepatitis B infection*
- **Maternal hepatitis B infection** is not a contraindication to breastfeeding, especially if the infant receives **hepatitis B vaccine** and **hepatitis B immunoglobulin (HBIG)** at birth.
- These interventions effectively protect the infant from acquiring the virus, and the benefits of breastfeeding for nutrition and immunity are significant.
*Smoking*
- While **smoking** by the mother is harmful and linked to various health issues in the infant, it is generally considered a strong caution rather than an absolute contraindication to breastfeeding.
- Mothers are encouraged to quit or reduce smoking, and to smoke away from the infant and breastfeed after a longer interval, but the immunological and nutritional benefits of breast milk still often outweigh the risks in mild to moderate smoking.
*Seropositive for cytomegalovirus*
- **Cytomegalovirus (CMV)** is excreted in breast milk by seropositive mothers, but for **healthy, term infants**, breastfeeding is generally considered safe and beneficial despite the presence of CMV antibodies.
- In contrast, for **premature or immunocompromised infants**, there might be a theoretical risk, and pasteurization of breast milk or temporary cessation might be considered, but it's not an absolute contraindication for a full-term, healthy baby.
Question 117: A 21-year-old gravida 1 presents to her physician's office for an antepartum visit at 11 weeks gestation. She has complaints of malaise, occasional nausea, and changes in food preferences. Her vital signs include: blood pressure 100/70 mm Hg, heart rate 90/min, respiratory rate 14/min, and temperature 36.8℃ (98.2℉). Examination reveals a systolic ejection murmur along the left sternal border. There are no changes in skin color, nails, or hair growth. No neck enlargement is noted. Blood analysis shows the following:
Erythrocyte count 3.5 million/mm3
Hb 11.9 g/dL
HCT 35%
Reticulocyte count 0.2%
MCV 85 fL
Platelet count 210,000/mm3
Leukocyte count 7800/mm3
Serum iron 17 µmol/L
Ferritin 120 µg/L
What is the most likely cause of the changes in the patient's blood count?
A. Increase in plasma volume (Correct Answer)
B. Failure of purine and thymidylate synthesis
C. Insufficient iron intake
D. Failure of synthesis of a D-aminolevulinic acid
E. Decreased iron transport across the intestinal wall
Explanation: ***Increase in plasma volume***
- The patient's **hemoglobin (Hb) of 11.9 g/dL**, **hematocrit (HCT) of 35%**, and **erythrocyte count of 3.5 million/mm3** are slightly below normal reference ranges. However, her **MCV (85 fL)** is normal, and **serum iron (17 µmol/L)** and **ferritin (120 µg/L)** are within healthy limits, indicating that iron stores are adequate.
- In pregnancy, a physiological **hemodilution** occurs due to a disproportionate increase in plasma volume compared to red blood cell mass. This leads to a relative decrease in Hb and HCT, which is normal and expected, rather than a true anemia.
*Failure of purine and thymidylate synthesis*
- This typically occurs in **megaloblastic anemias**, such as those caused by **folate or vitamin B12 deficiency**.
- Such anemias are characterized by **macrocytic red blood cells (high MCV)**, which is not seen here as the MCV is normal (85 fL).
*Insufficient iron intake*
- **Iron deficiency anemia** would present with significantly lower **serum iron** and **ferritin** levels, along with **microcytic (low MCV)** and **hypochromic** red blood cells.
- The patient's iron studies (serum iron 17 µmol/L, ferritin 120 µg/L) are normal, and her MCV is normal, ruling out iron deficiency.
*Failure of synthesis of a D-aminolevulinic acid*
- This refers to impaired heme synthesis, often seen in conditions like **sideroblastic anemia** or **lead poisoning**.
- These conditions typically cause **microcytic or dimorphic anemia** with **increased iron stores** and often **basophilic stippling**, none of which are indicated here.
*Decreased iron transport across the intestinal wall*
- This would result in **iron deficiency**, leading to low serum iron and ferritin, and potentially iron-deficiency anemia.
- As noted, the patient has **normal iron stores** (ferritin 120 µg/L) and serum iron levels, making impaired absorption unlikely to be the cause of her current blood counts.
Question 118: A 24-year-old woman comes to the physician for preconceptional advice. She has been married for 2 years and would like to conceive within the next year. Menses occur at regular 30-day intervals and last 4 days with normal flow. She does not smoke or drink alcohol and follows a balanced diet. She takes no medications. She is 160 cm (5 ft 3 in) tall and weighs 55 kg (121 lb); BMI is 21.5 kg/m2. Physical examination, including pelvic examination, shows no abnormalities. She has adequate knowledge of the fertile days of her menstrual cycle. Which of the following is most appropriate recommendation for this patient at this time?
A. Begin high-dose vitamin A supplementation
B. Begin vitamin B12 supplementation
C. Begin folate supplementation (Correct Answer)
D. Begin iron supplementation
E. Gain 2 kg prior to conception
Explanation: ***Begin folate supplementation***
- **Folate supplementation** of 400 mcg daily is recommended for all women of childbearing age to reduce the risk of **neural tube defects** (NTDs) in the fetus. This should ideally begin at least one month before conception and continue through the first trimester.
- The patient is planning to conceive, making preemptive folate supplementation critical for preventing serious birth defects.
*Begin high-dose vitamin A supplementation*
- **High-dose vitamin A** (more than 10,000 IU/day) can be **teratogenic** and is therefore contraindicated during preconception and pregnancy.
- While vitamin A is essential for fetal development, excessive amounts can lead to fetal abnormalities.
*Begin vitamin B12 supplementation*
- **Vitamin B12 supplementation** is generally not necessary unless the patient has a diagnosed deficiency, such as in strict vegetarians or those with malabsorption issues.
- There is no indication of B12 deficiency in this patient's history or presentation.
*Begin iron supplementation*
- Routine **iron supplementation** is not recommended preconception unless the patient is diagnosed with **iron deficiency anemia**.
- Excessive iron intake without a clear indication can cause gastrointestinal upset and has not been shown to improve pregnancy outcomes in non-anemic women.
*Gain 2 kg prior to conception*
- The patient has a **healthy BMI of 21.5 kg/m2**, which is within the normal range (18.5-24.9 kg/m2).
- There is no medical indication for her to gain weight prior to conception.
Question 119: A 21-year-old female presents to her primary care doctor for prenatal counseling before attempting to become pregnant for the first time. She is an avid runner, and the physician notes her BMI of 17.5. The patient complains of chronic fatigue, which she attributes to her busy lifestyle. The physician orders a complete blood count that reveals a Hgb 10.2 g/dL (normal 12.1 to 15.1 g/dL) with an MCV 102 µm^3 (normal 78 to 98 µm^3). A serum measurement of a catabolic derivative of methionine returns elevated. Which of the following complications is the patient at most risk for if she becomes pregnant?
A. Placenta abruptio (Correct Answer)
B. Placenta previa
C. Placenta accreta
D. Neural tube defects
E. Gestational diabetes
Explanation: **Placenta abruptio**
* The patient presents with several risk factors for **placental abruption**, including **low BMI**, **anemia** (Hgb 10.2), and **elevated homocysteine** (indicated by elevated catabolic derivative of methionine, implying **folate or B12 deficiency**, which leads to high homocysteine).
* **Anemia** and **folate deficiency** are associated with an increased risk of placental abruption.
*Placenta previa*
* **Placenta previa** is characterized by the placenta covering the cervical os, typically associated with risk factors like **previous C-section**, **multiparity**, and **advanced maternal age**.
* The patient's profile (first pregnancy, young) does not align with the typical risk factors for placenta previa.
*Placenta accreta*
* **Placenta accreta** involves abnormal placental adherence to the uterine wall, most commonly linked to **prior uterine surgery** (especially C-sections) and **placenta previa**.
* The patient has no history of uterine surgery, making placenta accreta an unlikely primary risk.
*Neural tube defects*
* **Neural tube defects** are associated with **folate deficiency**, which is likely present given the **macrocytic anemia** (MCV 102) and elevated homocysteine.
* However, the question asks for the complication the patient is *most* at risk for due to her overall profile including her low BMI and anemia, and while NTDs are a risk, the combination of factors points more strongly to placental abruption.
*Gestational diabetes*
* **Gestational diabetes** is linked to risk factors like **obesity**, **family history of diabetes**, and **advanced maternal age**.
* The patient's **low BMI** (17.5) and young age make gestational diabetes an unlikely significant risk.
Question 120: A 23-year-old woman presents to her physician requesting the chickenpox vaccine. She is also complaining of nausea, malaise, and moderate weight gain. She developed these symptoms gradually over the past 2 weeks. She reports no respiratory or cardiovascular disorders. Her last menstruation was about 6 weeks ago. She has one sexual partner and uses a natural planning method for contraception. Her vital signs include: blood pressure 110/70 mm Hg, heart rate 92/min, respiratory rate 14/min, and temperature 37.2℃ (99℉). The physical examination shows non-painful breast engorgement and nipple hyperpigmentation. There is no neck enlargement and no palpable nodules in the thyroid gland. The urine beta-hCG is positive. What is the proper recommendation regarding chickenpox vaccination in this patient?
A. Confirm pregnancy with serum beta-hCG and if positive delay administration of the vaccine until the third trimester.
B. Perform varicella viral load and schedule the vaccine based on these results.
C. Confirm pregnancy with serum beta-hCG and if positive, postpone administration of the vaccine until after completion of the pregnancy. (Correct Answer)
D. Schedule the vaccination.
E. Confirm pregnancy with serum beta-hCG and if positive, schedule the patient for pregnancy termination.
Explanation: ***Confirm pregnancy with serum beta-hCG and if positive, postpone administration of the vaccine until after completion of the pregnancy.***
- The patient's symptoms (nausea, malaise, weight gain, breast engorgement, nipple hyperpigmentation, missed menses) and a **positive urine beta-hCG** are highly indicative of **pregnancy**.
- The **chickenpox vaccine (varicella vaccine)** is a **live attenuated vaccine**, which is **contraindicated in pregnancy** due to the theoretical risk of fetal infection and congenital varicella syndrome. Vaccination should be deferred until after delivery.
*Confirm pregnancy with serum beta-hCG and if positive delay administration of the vaccine until the third trimester.*
- While confirming pregnancy with **serum beta-hCG** is appropriate, delaying vaccination only until the **third trimester** is still inappropriate for a live attenuated vaccine.
- Live attenuated vaccines are generally **contraindicated throughout pregnancy** due to potential fetal risks.
*Perform varicella viral load and schedule the vaccine based on these results.*
- A **varicella viral load** test is used to detect active viral infections, not to determine immunity or the need for vaccination in an uninfected individual.
- The primary concern here is the patient's likely pregnancy, not current varicella infection status.
*Schedule the vaccination.*
- Given the strong suspicion of **pregnancy** and a **positive urine beta-hCG**, immediately scheduling a live attenuated vaccine like the chickenpox vaccine would be **medically inappropriate and potentially harmful** to the fetus.
- Vaccination must be deferred until pregnancy status is confirmed and, if positive, until after delivery.
*Confirm pregnancy with serum beta-hCG and if positive, schedule the patient for pregnancy termination.*
- A potential need for a chickenpox vaccine, even if the patient is pregnant, is not an indication for **pregnancy termination**.
- This option is ethically and medically unsound, as exposure to the varicella vaccine in pregnancy does not warrant termination.